Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Obstructive Lung Diseases

  Free Subscription


Articles published in Rev Mal Respir

Retrieve available abstracts of 32 articles:
HTML format



Single Articles


    October 2025
  1. GUENDOUZ A, Matmour D, Benabdi S
    [The particularities of asthma in the elderly subject: A comparative study in an Algerian population].
    Rev Mal Respir. 2025 Oct 30:S0761-8425(25)00245.
    PubMed     Abstract available


  2. MILESI J, Naud R, Delliaux S, Bregeon F, et al
    [Surgical emphysema reduction: A viable alternative in the era of endobronchial valves].
    Rev Mal Respir. 2025 Oct 3:S0761-8425(25)00225-6. doi: 10.1016/j.rmr.2025.
    PubMed     Abstract available


    September 2025
  3. AGUILANIU B, Cittee J, Watier L, Pribil C, et al
    [Use of fluticasone/umeclidinium/vilanterol in France: A population based study].
    Rev Mal Respir. 2025;42:331-342.
    PubMed     Abstract available


    August 2025
  4. LEJEUNE S, Wanin S, Amat F, Lezmi G, et al
    [Guidelines from the SP2A (Pediatric Society of Pulmonology and Allergology) for the management of asthma in children aged 6 to 12years (without management of asthma exacerbation) - Short version].
    Rev Mal Respir. 2025 Aug 29:S0761-8425(25)00209.
    PubMed    


    July 2025
  5. DIDIER A, Camus C, Lemeur A, Bieler L, et al
    [Emergency room visits for asthma and the reported outcomes: The PASS survey by the CRISALIS network].
    Rev Mal Respir. 2025 Jul 24:S0761-8425(25)00208.
    PubMed     Abstract available


  6. MBA NDONG JG, Bourobou Bourobou JA, Ngoungou E, Aboughe Angone S, et al
    [Epidemiology of childhood asthma in sub-Saharan Africa: A systematic literature review].
    Rev Mal Respir. 2025 Jul 9:S0761-8425(25)00204-9. doi: 10.1016/j.rmr.2025.
    PubMed     Abstract available


    May 2025
  7. GROSZ T, Calcaianu G, Palpacuer C, Riou M, et al
    [Evaluation of compliance with prescription proposals for COPD in the Alsace region of France].
    Rev Mal Respir. 2025;42:243-251.
    PubMed     Abstract available


    March 2025
  8. CHARPIN D, Brun O
    [Wildfires and their respiratory impact].
    Rev Mal Respir. 2025;42:159-167.
    PubMed     Abstract available


  9. MAZENQ J, Dubus JC, Chanez P, Gras D, et al
    [Post-infectious bronchiolitis obliterans in children: A rare and potentially devastating disease].
    Rev Mal Respir. 2025;42:148-152.
    PubMed     Abstract available


    February 2025
  10. BERGEREAU H, Hassoun D, Marquant Q, Rousselle M, et al
    [Impact of Rac1 activation on eosinophil degranulation in severe asthma].
    Rev Mal Respir. 2025 Feb 26:S0761-8425(25)00049.
    PubMed     Abstract available


    January 2025
  11. TEULIER M, Fouquereau E, Bremond M, Courtois R, et al
    [Psychosocial traits associated with maintenance of physical activity 12months after a pulmonary rehabilitation program - An exploratory study].
    Rev Mal Respir. 2025;42:38-47.
    PubMed     Abstract available


    December 2024
  12. MERIENNE A, Claude Roux P, Chassagne A
    [Understanding teenagers' experiences of asthma. A qualitative approach to adolescents' perceptions of the disease and management of the symptoms].
    Rev Mal Respir. 2024 Dec 10:S0761-8425(24)00340.
    PubMed     Abstract available


  13. SANDOT A, Bunel V, Mal H
    [Indications of home oxygen therapy for patients with COPD or ILD].
    Rev Mal Respir. 2024;41:751-761.
    PubMed     Abstract available


  14. ROCHE N, Bernady A, Piperno D, Bachiri A, et al
    [Real-life utilization of fixed triple therapy in COPD: The Trilife study. Beclomethasone/formoterol/glycopyrronium triple fixed-dose therapy in extra-fine particles].
    Rev Mal Respir. 2024;41:715-726.
    PubMed     Abstract available


  15. DOURNES G, Zysman M, Benlala I, Berger P, et al
    [CT imaging of chronic obstructive pulmonary disease: What aspects and what role?].
    Rev Mal Respir. 2024;41:738-750.
    PubMed     Abstract available


    November 2024
  16. REGARD L, Lazureanu PC, Pascal B, Laurichesse G, et al
    [Efficacy and toxicity of short-course corticosteroid therapy in chronic bronchial diseases].
    Rev Mal Respir. 2024;41:696-712.
    PubMed     Abstract available


    October 2024
  17. THIBAUT DE MENONVILLE C, Barakat L, Laborier F, Le Brun M, et al
    [Efficacy of biologics for severe asthma on allergic comorbidities].
    Rev Mal Respir. 2024 Oct 4:S0761-8425(24)00274-2. doi: 10.1016/j.rmr.2024.
    PubMed     Abstract available


    September 2024
  18. MARGUET C, Gregoire, Werner A, Cracco O, et al
    [Management of asthma attack in children aged 6 to 12 years].
    Rev Mal Respir. 2024 Sep 9:S0761-8425(24)00246-8. doi: 10.1016/j.rmr.2024.
    PubMed    


  19. BEYDON N, Abou Taam R, Delclaux C, Du Boisbaudry C, et al
    [Pulmonary function test: The testing of children].
    Rev Mal Respir. 2024;41:488-497.
    PubMed     Abstract available


  20. RUELLAND C, Beaumont M
    [Effects of gender on pulmonary rehabilitation outcomes in patients with COPD].
    Rev Mal Respir. 2024;41:463-471.
    PubMed     Abstract available


  21. GIRAULT C, Artaud-Macari E, Jolly G, Carpentier D, et al
    [High-flow nasal oxygen therapy and hypercapnic acute respiratory failure].
    Rev Mal Respir. 2024;41:498-507.
    PubMed     Abstract available


    August 2024
  22. LEJEUNE S, Hullo E, Bierme P, Baravalle M, et al
    [From difficult-to-treat asthma to severe asthma: Step 5].
    Rev Mal Respir. 2024 Aug 26:S0761-8425(24)00245.
    PubMed    


    June 2024
  23. ROCHE N, Caron A, Emery C, Torreton E, et al
    [Medico-economic evaluation of the PRADO-BPCO post-exacerbation support program].
    Rev Mal Respir. 2024;41:409-420.
    PubMed     Abstract available


  24. ALEXANDRE F, Molinier V, Poulain M, Villiot-Danger E, et al
    [French survey of patients on current and future pulmonary rehabilitation programs].
    Rev Mal Respir. 2024;41:399-408.
    PubMed     Abstract available


    May 2024
  25. DESLEE G, Le Rouzic O, Zysman M, Roche N, et al
    [Second COPD biennial of the French Society of Respiratory Diseases: Major changes].
    Rev Mal Respir. 2024;41:329-330.
    PubMed    


  26. ANCEL J, Chen E, Pavot A, Regard L, et al
    [Take-home messages from the 2nd COPD 2023 Biennial of the French Society of Respiratory Diseases. Placing the patient at the center of the care pathway].
    Rev Mal Respir. 2024;41:331-342.
    PubMed     Abstract available


  27. JESTIN-GUYON N, Raherison-Semjen C
    [Pesticide exposure and chronic respiratory diseases].
    Rev Mal Respir. 2024;41:343-371.
    PubMed     Abstract available


    April 2024
  28. DARGENTOLLE G, Georges M, Beltramo G, Poisson C, et al
    [Adverse events in biologics for severe asthma].
    Rev Mal Respir. 2024 Apr 22:S0761-8425(24)00190.
    PubMed     Abstract available


  29. RAASCH K, Dupin I
    [Modifications of distal pathways in COPD, in light of recent technological advances in imaging and transcriptomics].
    Rev Mal Respir. 2024;41:269-273.
    PubMed     Abstract available


    March 2024
  30. JUSTEAU G, Toigo M, Castro de Freitas T, Ribeiro Baptista B, et al
    [Pulmonary lipofibroblasts in adults and alveolar regeneration in emphysema].
    Rev Mal Respir. 2024 Mar 8:S0761-8425(24)00145-1. doi: 10.1016/j.rmr.2024.
    PubMed     Abstract available


  31. AHMED E, Assou S, Foisset F, Bourdais C, et al
    [Modeling T2 high severe asthma using human induced pluripotent stem cells (hiPSC)].
    Rev Mal Respir. 2024 Mar 8:S0761-8425(24)00142-6. doi: 10.1016/j.rmr.2024.
    PubMed     Abstract available


    February 2024
  32. GADDOUR A, Chatti S, Chouchene A, Kacem I, et al
    [An epidemiological and evolutionary profile of occupational asthma of Tunisian workers].
    Rev Mal Respir. 2024 Feb 29:S0761-8425(24)00116.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.